Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions

Area of Science:

• Neuroscience
• Molecular Biology
• Cellular Signaling

Background:

• The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) cascade, mammalian target of rapamycin (mTOR), and peroxisome proliferator-activated receptor-gamma (PPARγ) are key signaling pathways.
• These pathways are crucial for neuronal activity, brain development, cell metabolism, and differentiation.
• Dysregulation of JAK-STAT, mTOR, and PPARγ signaling is implicated in neuroinflammation, apoptosis, and oxidative stress, contributing to neurological and neuropsychiatric disorders.

Purpose of the Study:

• To review the therapeutic potential of modulators targeting the JAK-STAT, mTOR, and PPARγ signaling pathways.
• To explore the role of these pathways in coordinating neuronal activity and brain development.
• To examine how targeting these pathways can prevent or alleviate neuronal complications.

Main Methods:

• Literature review of preclinical and clinical investigations.
• Analysis of studies focusing on JAK-STAT, mTOR, and PPARγ signaling pathways.
• Exploration of therapeutic interventions targeting these signaling hubs.

Main Results:

• Overactivation of JAK/STAT and mTOR, and inhibition of PPARγ signaling are linked to neurocomplications.
• Target modulators have demonstrated efficacy in alleviating neuronal complications in various studies.
• These pathways represent a conserved signaling hub critical for brain function.

Conclusions:

• Modulators of JAK-STAT, mTOR, and PPARγ signaling hold therapeutic promise for neurological and neuropsychiatric diseases.
• Targeting these conserved signaling pathways could offer novel strategies for treating acute and chronic neurological deficits.
• Further research into these modulators is warranted to fully understand their clinical applications.